Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases

• Published in: Experimental biology and medicine (Maywood, N.J.) Vol. 236; no. 6; p. 637
• Main Authors: Choi, Won-Tak, An, Jing
• Format: Journal Article
• Language: English
• Published: England 01.06.2011
• Subjects: Animals; Chemokines - immunology; Chemokines - toxicity; Humans; Immune System - physiology; Immune System - physiopathology; Receptors, CCR5 - immunology; Receptors, CXCR4 - immunology; Signal Transduction
• ISSN: 1535-3699
• DOI: 10.1258/ebm.2011.010389

Chemokines and their receptors are implicated in a wide range of human diseases, including acquired immune deficiency syndrome (AIDS). The entry of human immunodeficiency virus type 1 (HIV-1) into a cell is initiated by the interaction of the virus's surface envelope proteins with two cell surface components of the target cell, namely CD4 and a chemokine co-receptor, usually CXCR4 or CCR5. Typical anti-HIV-1 agents include protease and reverse transcriptase inhibitors, but the targets of these agents tend to show rapid mutation rates. As such, strategies based on HIV-1 co-receptors have appeal because they target invariant host determinants. Chemokines and their receptors are also of general interest since they play important roles in numerous physiological and pathological processes in addition to AIDS. Therefore, intensive basic and translational research is ongoing for the dissection of their structure - function relationships in an effort to understand the molecular mechanism of chemokine - receptor interactions and signal transductions across cellular membranes. This paper reviews and discusses recent advances and the translation of new knowledge and discoveries into novel interventional strategies for clinical application.